ArticleJournal of the American Society of Nephrology : JASN2026
Dual B -Cell Maturation Antigen/CD19 Chimeric Antigen Receptor- T Therapy for AL Amyloidosis : Targeting the Clone, Saving the Kidney.
Klaudia Sobczak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.